Meta-analysis of blood cortisol levels in individuals with first-episode psychosis

Daniel B. Hubbard, Brian J Miller

Research output: Contribution to journalArticle

Abstract

Objective: Schizophrenia is associated with abnormal neuroimmunoendocrine function. There is evidence for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in individuals with first-episode psychosis (FEP). However, some previous meta-analyses have focused on heterogeneous sample sources and patient populations. We performed a meta-analysis of baseline (i.e., one sample) blood cortisol levels in individuals with FEP and minimal exposure to antipsychotics. Method: Articles were identified by searching PubMed, PsycInfo, Web of Science, and Science Direct, and the reference lists of these studies. Results: Twenty-six studies (comprising twenty-seven samples) met the inclusion criteria. Blood cortisol levels were significantly increased in individuals with FEP compared to controls with a small-to-medium effect size (standard mean difference [SMD] = 0.37, 95% CI 0.16-0.57, p < 0.001). In meta-regression analyses, geography was a significant moderator of this association, with larger effects seen in studies conducted in Asia versus the Middle East. Conclusion: We found elevated blood cortisol levels in individuals with FEP, providing additional, complementary evidence for abnormal HPA axis function in this disorder. This finding, which does not inform on mechanism, is consistent with the “neural diathesis-stress” model of psychosis. Given the immunomodulatory effects of cortisol, methodologically rigorous longitudinal studies of cortisol parameters, inflammatory markers, and psychopathology in this patient population are warranted.

Original languageEnglish (US)
Pages (from-to)269-275
Number of pages7
JournalPsychoneuroendocrinology
Volume104
DOIs
StatePublished - Jun 1 2019

Fingerprint

Psychotic Disorders
Hydrocortisone
Meta-Analysis
Geography
Middle East
Disease Susceptibility
Psychopathology
PubMed
Antipsychotic Agents
Population
Longitudinal Studies
Schizophrenia
Regression Analysis

Keywords

  • Antipsychotic-naïve
  • Blood
  • Cortisol
  • First-episode psychosis
  • Meta-analysis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Meta-analysis of blood cortisol levels in individuals with first-episode psychosis. / Hubbard, Daniel B.; Miller, Brian J.

In: Psychoneuroendocrinology, Vol. 104, 01.06.2019, p. 269-275.

Research output: Contribution to journalArticle

@article{b7c75807f6f24a2488dbd8eece9a125c,
title = "Meta-analysis of blood cortisol levels in individuals with first-episode psychosis",
abstract = "Objective: Schizophrenia is associated with abnormal neuroimmunoendocrine function. There is evidence for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in individuals with first-episode psychosis (FEP). However, some previous meta-analyses have focused on heterogeneous sample sources and patient populations. We performed a meta-analysis of baseline (i.e., one sample) blood cortisol levels in individuals with FEP and minimal exposure to antipsychotics. Method: Articles were identified by searching PubMed, PsycInfo, Web of Science, and Science Direct, and the reference lists of these studies. Results: Twenty-six studies (comprising twenty-seven samples) met the inclusion criteria. Blood cortisol levels were significantly increased in individuals with FEP compared to controls with a small-to-medium effect size (standard mean difference [SMD] = 0.37, 95{\%} CI 0.16-0.57, p < 0.001). In meta-regression analyses, geography was a significant moderator of this association, with larger effects seen in studies conducted in Asia versus the Middle East. Conclusion: We found elevated blood cortisol levels in individuals with FEP, providing additional, complementary evidence for abnormal HPA axis function in this disorder. This finding, which does not inform on mechanism, is consistent with the “neural diathesis-stress” model of psychosis. Given the immunomodulatory effects of cortisol, methodologically rigorous longitudinal studies of cortisol parameters, inflammatory markers, and psychopathology in this patient population are warranted.",
keywords = "Antipsychotic-na{\"i}ve, Blood, Cortisol, First-episode psychosis, Meta-analysis",
author = "Hubbard, {Daniel B.} and Miller, {Brian J}",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.psyneuen.2019.03.014",
language = "English (US)",
volume = "104",
pages = "269--275",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Meta-analysis of blood cortisol levels in individuals with first-episode psychosis

AU - Hubbard, Daniel B.

AU - Miller, Brian J

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Objective: Schizophrenia is associated with abnormal neuroimmunoendocrine function. There is evidence for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in individuals with first-episode psychosis (FEP). However, some previous meta-analyses have focused on heterogeneous sample sources and patient populations. We performed a meta-analysis of baseline (i.e., one sample) blood cortisol levels in individuals with FEP and minimal exposure to antipsychotics. Method: Articles were identified by searching PubMed, PsycInfo, Web of Science, and Science Direct, and the reference lists of these studies. Results: Twenty-six studies (comprising twenty-seven samples) met the inclusion criteria. Blood cortisol levels were significantly increased in individuals with FEP compared to controls with a small-to-medium effect size (standard mean difference [SMD] = 0.37, 95% CI 0.16-0.57, p < 0.001). In meta-regression analyses, geography was a significant moderator of this association, with larger effects seen in studies conducted in Asia versus the Middle East. Conclusion: We found elevated blood cortisol levels in individuals with FEP, providing additional, complementary evidence for abnormal HPA axis function in this disorder. This finding, which does not inform on mechanism, is consistent with the “neural diathesis-stress” model of psychosis. Given the immunomodulatory effects of cortisol, methodologically rigorous longitudinal studies of cortisol parameters, inflammatory markers, and psychopathology in this patient population are warranted.

AB - Objective: Schizophrenia is associated with abnormal neuroimmunoendocrine function. There is evidence for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in individuals with first-episode psychosis (FEP). However, some previous meta-analyses have focused on heterogeneous sample sources and patient populations. We performed a meta-analysis of baseline (i.e., one sample) blood cortisol levels in individuals with FEP and minimal exposure to antipsychotics. Method: Articles were identified by searching PubMed, PsycInfo, Web of Science, and Science Direct, and the reference lists of these studies. Results: Twenty-six studies (comprising twenty-seven samples) met the inclusion criteria. Blood cortisol levels were significantly increased in individuals with FEP compared to controls with a small-to-medium effect size (standard mean difference [SMD] = 0.37, 95% CI 0.16-0.57, p < 0.001). In meta-regression analyses, geography was a significant moderator of this association, with larger effects seen in studies conducted in Asia versus the Middle East. Conclusion: We found elevated blood cortisol levels in individuals with FEP, providing additional, complementary evidence for abnormal HPA axis function in this disorder. This finding, which does not inform on mechanism, is consistent with the “neural diathesis-stress” model of psychosis. Given the immunomodulatory effects of cortisol, methodologically rigorous longitudinal studies of cortisol parameters, inflammatory markers, and psychopathology in this patient population are warranted.

KW - Antipsychotic-naïve

KW - Blood

KW - Cortisol

KW - First-episode psychosis

KW - Meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=85063203754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063203754&partnerID=8YFLogxK

U2 - 10.1016/j.psyneuen.2019.03.014

DO - 10.1016/j.psyneuen.2019.03.014

M3 - Article

VL - 104

SP - 269

EP - 275

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

ER -